QUESTIONS_AND_ANSWERS_Studies_to_Enhance_FDA_Communications_Medical_Countermeasures_4.doc

DOC document 23 KB Posted

Attached to
Studies to Enhance FDA Communications Addressing Medical Countermeasures Prescription Drug Products
Solicitation number
FDA-16-RFP-1160119
Issued by

About this file

Q and A Studies to Enhance FDA Communications Medical Countermeasures 4

View the file

Other files

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

QUESTIONS AND ANSWERS #4

SOLICITATION NUMBER # FDA-16-RFP-1160119

Studies to Enhance FDA Communications Addressing Medical Countermeasures

Question 01 In the budget table, part 2.1 of the RFP, there is a request for a line item "Approved Final Reports and Presentation: Focus Groups/Web Survey" (four lines from the bottom of Page 1 of the document. There is no accompanying description of this line item or the Deliverables associated with it. Could you clarify please?

Answer 01 (See Amendment 02) That appears to be an error/duplication. As noted on other sections of that deliverables chart, the focus group draft and final reports are covered by tasks 8 and 9; survey draft and final reports are covered by tasks 12 and 14 (partial); presentation of combined results is covered by task 17.

THERE WILL BE NO MORE QUESTIONS ANSWERED AT THIS TIME

File details come from the government source that posted it. Updated .